You are here

A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Research site
Overland Park, Kansas, United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-50 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Provision of signed and dated, written informed consent prior to any study-specific
procedures.

- Healthy male and female subjects aged 18 to 50 years (inclusive) with suitable veins
for cannulation or repeated venipuncture; female subjects must be post menopausal or
surgically sterile.

- Male subjects should be willing to use barrier contraception ie, condoms, from the
first day of the investigational product administration until 3 months after the last
administration of the investigational product.

- Have a body mass index (BMI) between 19 and 30 kg/m2

- Be able to understand and willing to comply with study procedures, restrictions, and
requirements, as judged by the Investigator

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of any clinically significant disease or disorder which, in the opinion of the
Investigator, may either put the subject at risk because of participation in the
study, or influence the results or the subject's ability to participate in the study

- History or presence of gastrointestinal, hepatic or renal disease, or any other
condition known to interfere with absorption, distribution, metabolism, or excretion
of drugs

- Known history of serious allergy, hypersensitivity (eg, anaphylaxis), or any serious
reaction to carbapenem or cephalosporin antibiotics or other beta-actam antibiotics or
any other investigational product to be administered as part of the study

- Any clinically significant illness, medical/surgical procedure or trauma within 4
weeks prior to the first administration of investigational product Any clinically
significant abnormalities in physical examination, ECG, clinical chemistry,
haematology, or urinalysis results, as judged by the Investigator

NCT01534247
Pfizer
Completed
A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Healthy Participants
NCT03916393
All Genders
18+
Years
Brussels, Be-bru
Healthy
NCT03599063
All Genders
18+
Years
New Haven, Connecticut

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now